Clinical trial
Randomized, Double-Blind, Placebo-Controlled, Parallel Study on the Effects of Effera Human Lactoferrin on Gastrointestinal Permeability
NCT07035964 is registered in ClinicalTrials.gov with Helaina Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-Blind, Placebo-Controlled, Parallel Study on the Effects of Effera Human Lactoferrin on Gastrointestinal Permeability
- Lead sponsor
- Helaina Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 4, 2025
- Completion date
- August 30, 2025
- Enrollment
- 46 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gut health, gut permeability